Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989

New England Journal of Medicine

Volumn 340, Issue 16, 1999, Pages 1221-1227

  Mosterd, Arend ^a,b   D'Agostino, Ralph B ^a   Silbershatz, Halit ^a   Sytkowski, Pamela A ^a   Kannel, William B ^a   Grobbee, Diederick E ^b,c   Levy, Daniel ^a,d,e  

^a Blood Inst's F   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e FRAMINGHAM HEART STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BODY MASS INDEX; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 0033594513     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199904223401601     Document Type: Article

References (38)

1. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993;153: 598-615.
2. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-45. [Erratum, Arch Intern Med 1998;158:573.]
3. The fifth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993;153:154-83.
4. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-13.
5. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827-38.
6. Sytkowski PA, D'Agostino RB, Belanger AJ, Kannel WB. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality: the Framingham Heart Study 1950 to 1990. Circulation 1996;93:697-703.
7. Goldman L, Cook EF. The decline in ischemic heart disease mortality rates: an analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med 1984;101:825-36.
8. Hunink MG, Goldman L, Tosteson AN, et al. The recent decline in mortality from coronary heart disease, 1980-1990: the effect of secular trends in risk factors and treatment. JAMA 1997;277:535-42.
9. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998;339:861-7.
10. Levy D, Thom TJ. Death rates from coronary disease - progress and a puzzling paradox. N Engl J Med 1998;339:915-7.
11. Frohlich ED, Apstein C, Chobanian AV, et al. The heart in hypertension. N Engl J Med 1992;327:998-1008. [Erratum, N Engl J Med 1992; 327:1768.]
12. Chambers J. Left ventricular hypertrophy. BMJ 1995;311:273-4.
13. MacMahon S, Collins G, Rautaharju P, et al. Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial. Am J Cardiol 1989;63:202-10.
14. Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994;90: 1786-93.
15. Sullivan JM, Vander Zwaag RV, el-Zeky F, Ramanathan KB, Mirvis DM. Left ventricular hypertrophy: effect on survival. J Am Coll Cardiol 1993;22:508-13.
16. Knutsen R, Knutsen SF, Curb JD, Reed DM, Kautz JA, Yano K. The predictive value of resting electrocardiograms for 12-year incidence of coronary heart disease in the Honolulu Heart Program. J Clin Epidemiol 1988;41:293-302.
17. The Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program: prevention and reversal of left ventricular hypertrophy with antihypertensive drug therapy. Hypertension 1985;7:105-12.
18. Ashizawa N, Seto S, Kitano K, et al. Effects of blood pressure changes on development and regression of electrocardiographic left ventricular hypertrophy: a 26 year longitudinal study. J Am Coll Cardiol 1989;13:165-72.
19. Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized double-blind studies. JAMA 1996;275:1507-13.
20. Dawber TR, Meadors GF, Moore FE Jr. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health 1951;41:279-81.
21. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol 1979;110:281-90.
22. Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation 1987;75:565-72.
23. Casale PN, Devereux RB, Kligfield P, et al. Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol 1985;6:572-80.
24. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1988;73:13-22.
25. D'Agostino RB, Lee ML, Belanger AJ, Cupples LA, Anderson KA, Kannel WB. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med 1990;9:1501-15.
26. Kannel WB, Wolf PA. Inferences from secular trend analysis of hypertension control. Am J Public Health 1992;82:1593-5.
27. Sytkowski PA, D'Agostino RB, Belanger AJ, Kannel WB. Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989. Am J Epidemiol 1996;143:338-50.
28. Sprafka JM, Burke GL, Folsom AR, Luepker RV, Blackburn H. Continued decline in cardiovascular disease risk factors: results of the Minnesota Heart Survey, 1980-1982 and 1985-1987. Am J Epidemiol 1990; 132:489-500.
29. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994;272:205-11.
30. Pringle SD, Macfarlane PW, McKillop JH, Lorimer AR, Dunn FG. Pathophysiologic assessment of left ventricular hypertrophy and strain in asymptomatic patients with essential hypertension. J Am Coll Cardiol 1989;13:1377-81.
31. Ghali JK, Kadakia S, Cooper RS, Liao YL. Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease. J Am Coll Cardiol 1991;17:1277-82.
32. McLenachan JM, Henderson E, Morris KI, Dargie HJ, Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987;317:787-92.
33. Lanti M, Puddu PE, Menotti A. Voltage criteria of left ventricular hypertrophy in sudden and nonsudden coronary artery disease mortality: the Italian section of the Seven Countries Study. Am J Cardiol 1990;66:1181-5.
34. Van Hoof R. Left ventricular hypertrophy in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly trial. Am J Med 1991;90:Suppl 3A:55S-59S.
35. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998;97:48-54.
36. Morbidity and mortality: 1998 chartbook on cardiovascular, lung, and blood diseases. Rockville, Md.: National Heart, Lung, and Blood Institute, 1998.
37. Feinleib M, Pinsky J. Nonrandom attrition in the Framingham Heart Study: application: age trends in blood pressure. In: Dwyer JH, Feinleib M, Lippert P, Hoffmeister H, eds. Statistical models for longitudinal studies of health. Vol. 16 of Monographs in epidemiology and biostatistics. New York: Oxford University Press, 1992:16:261-76.
38. Lee DK, Marantz PR, Devereux RB, Kligfield P, Alderman MH. Left ventricular hypertrophy in black and white hypertensives: standard electrocardiographic criteria overestimate racial differences in prevalence. JAMA 1992;267:3294-9. [Erratum, JAMA 1992;268:3201.]